|
Nkarta Inc (NASDAQ: NKTX) |
|
Nkarta Inc
NKTX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Nkarta Inc 's sales fell
in the fourth quarter of 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.85 %
Nkarta Inc net loss decreased from $-28 millions, to $-26 millions in fourth quarter of 2024,
• More on NKTX's Growth
|
|
Nkarta Inc realized a net loss in trailing twelve months.
Nkarta Inc realized cash reduction of $ -0.05 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.
• More on NKTX's Valuation
|
|
|
|
|
Nkarta Inc realized net loss in trailing twelve months.
Nkarta Inc realized cash outflow of $ -0.05per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.
Nkarta Inc Price to Book Ratio is at 0.29 lower than Industry Avg. of 33.12. and higher than S&P 500 Avg. of 0.01
• More on NKTX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com